Previous Page  9 / 20 Next Page
Information
Show Menu
Previous Page 9 / 20 Next Page
Page Background

Page 22

Notes:

allied

academies

September 20-21, 2017 | Philadelphia, USA

Global summit on

TUBERCULOSIS AND LUNG DISEASE

Int J Respir Med 2017 Volume 2 Issue 2

Pharmacological therapy of asthma during pregnancy

Iram A

National University Hospital Rigshospitalet Glostrup, Denmark

A

sthma is one of the most frequent chronic diseases that

complicate pregnancy. Well-controlled asthma during

pregnancy reduces the risk for an exacerbation during

pregnancy. Pharmacological asthma therapy in pregnant

women is a challenge due to suboptimal adherence with

controller therapy, pregnant women’s and professional

health care’s concerns about harmful effects of medication

on the fetus. These aspects make it necessary to evaluate

the harmful effects of pharmacological asthma therapy

and poor asthma control during pregnancy. The aim for my

presentation is to provide an update on safety of asthma

medication during pregnancy, based on recent clinical

studies and International Guidelines.

Speaker Biography

Iram A has completed her Master’s degree from Copenhagen University, Denmark. She

is a Resident and Researcher with asthma among pregnant women as field of interest.

She has published one article and is going to publish her second article.

e:

iram_akram@Hotmail.com